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ABSTRACT 
 
 
Background: The Carer Support Needs Assessment Tool intervention (CSNAT-I) has been shown 
to improve end-of-life care support for informal caregivers. This study investigated the impact of 
the CSNAT-I on caregivers of patients recently enrolled in specialised palliative care (SPC) at home 
in Denmark. 
 
Methods: A stepped-wedge cluster randomised controlled trial with nine clusters (i.e., SPC teams). 
Outcome measures were collected using caregiver questionnaires at baseline (T0) and two (T1) and 
four (T2) weeks follow-up. ClinicalTrials.gov ID: NCT03466580. 
 
Results: A total of 437 caregivers were enrolled (control group, n=255; intervention group, n=182). 
No intervention effect was found on the primary outcome, caregiver strain at T1 (p = 0.1865). 
However, positive effects were found at T1 and T2 on attention to caregivers’ wellbeing (p < 
0.0001), quality of information and communication (p < 0.0001), amount of information (T1: p = 
0.0002; T2: p < 0.0001), involvement (T1: p = 0.0045; T2: p < 0.0001), talking about greatest 
burdens (p < 0.0001) and assistance in managing greatest burdens (p < 0.0001). The effect sizes of 
these differences were medium or large and seemed to increase from T1 to T2. At T1, positive 
effects were found on distress (p = 0.0178) and home care responsibility (p = 0.0024). No effect 
was found on the remaining outcomes. 
 
Conclusion: Although no effect was found on caregiver strain, the CSNAT-I showed positive 
effects on caregiver distress, home care responsibility and key outcomes regarding caregivers’ 
experience of the interaction with health care professionals. 
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INTRODUCTION 
Informal caregivers are central to the support and care of patients,[1;2], particularly when the 
patient is cared for at home,[3;4]. However, caregivers themselves can be considered ‘hidden 
patients’,[5] as they may experience physical, psychological and social morbidity,[6] because the 
role as caregiver can be overwhelming, go on for years, and may increase towards the end of 
life,[7;8].  
Yet, even in modern specialised palliative care (SPC) where caregiver support is a core function,[9],  
caregivers do not always feel well supported: they may lack information,[10] and feel overlooked 
and  that their care expertise is not taken into consideration,[11]. In a study amongst Danish patients 
who were in contact with an SPC team/hospice, a large proportion reported room for improvement 
in caregiver support, and in the qualitative comments, the patients asked for more support for the 
family,[12]. Also, in a survey amongst 590 Danish cancer caregivers, a large proportion of 
caregivers reported lack of support, attention, and information, and insufficient involvement in the 
patients’ disease, treatment and/or care,[13]. Evidence-based interventions and strategies to assess 
and respond to caregivers’ needs have been lacking,[14;15].  
The Carer Support Needs Assessment Tool intervention (CSNAT-I) was developed to respond to 
these problems,[16;17]. The intervention specifically targets caregivers of patients receiving end-of-
life care at home and was developed on the basis of qualitative research (focus group and telephone 
interviews with 75 bereaved caregivers),[16] and validated in 225 caregivers in Hospice Home Care 
services,[17]. The CSNAT-I is underpinned by a person-centred framework in which the caregiver 
is taking the lead, and the health care professional (HCP) is working ‘with’ rather than doing ‘to’ 
the caregiver,[18] The CSNAT-I has shown positive effects in studies from Australia and the 
UK,[19-21] and has been valued by both caregivers and HCPs,[22-24].  
Whilst the CSNAT-I seems to be a promising, available method to improve support to caregivers of 
patients in SPC at home in Denmark, evaluation of the intervention in this setting has not been 
done.  
Thus, the aim of the present study was to investigate the impact of the CSNAT-I on caregivers of 
patients who recently started in SPC at home in Denmark: what is the effect of the intervention on 
caregiver strain, distress, positive caregiving appraisals, experiences of the interaction with HCPs, 
workload, emotional functioning, fatigue and quality of life? 
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METHODS 
Setting 
In Denmark, SPC is delivered as in-patient care at hospices or hospital SPC departments, or as out-
patient care from these units in the home or in out-patient clinics. SPC teams are interdisciplinary 
and comprise specialised medical doctors and nurses and e.g., physiotherapists, social workers, 
psychologists and priests. Of the 24 SPC teams delivering out-patient care in Denmark (in 2017), 
nine consented to participate in the present study (Figure 1).  
Study design 
The study was a stepped-wedge cluster randomised controlled trial (SW-CRT),[25;26]. In an SW-
CRT, every cluster first acts as a control and later as an intervention site. The time of transition 
varies and is determined by randomisation. The SW-CRT design was chosen to account for 
variation between SPC units, to prevent contamination, and to make participation in the study 
attractive for SPC units as all units ultimately will deliver the intervention,[25;26]. 
All participating SPC teams (i.e., clusters) had an enrolment period of 12 months. The shift from 
pre-intervention period (control period) to intervention period was at either 3, 6 or 9 months (Figure 
1). The randomisation was computer based (carried out by the research group) and allocated three 
SPC teams to shift to intervention period at each of the three time points. 
Study population 
The study population was primary caregivers of patients recently started in SPC delivered by an 
SPC team. In Denmark, patients receiving SPC are almost exclusively cancer patients. Cancer 
patients starting in SPC have a very high symptom load (especially fatigue, anorexia and pain), poor 
level of physical functioning and low quality of life. In 2018 and 2019, the median survival time 
from start of SPC was 42 and 40 days, respectively,[27;28] 
‘Primary caregiver’ was defined as the lay person whom the patient considered most involved in 
his/her disease course. Caregivers had to be adults (18 years and over) who were able to read and 
understand Danish and who were caring for adult patients who were able to read and understand 
Danish and who had not received any kind of SPC before. Caregivers were not eligible for the study 
if they had a known cognitive impairment precluding participation or, based on the HCP’s clinical 
judgement, were too distressed to cope with research.  
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Enrolment procedure 
HCPs briefly introduced caregivers and patients to the study and if they both consented, the 
research group contacted the caregiver, provided comprehensive information about the study and 
enrolled him/her in the study. Details of the enrolment procedure are shown in Figure 2.  
Intervention  
Content and delivery 
The CSNAT-I has two parts: 1) an evidence-based tool (the CSNAT) consisting of 14 support 
domains covering the support that caregivers need to a) care for the patient (caregiver as co-worker) 
and b) look after their own health and well-being (caregiver as client),[16] (Box 1). The tool itself is 
integrated into 2) a five-stage person-centred framework which is HCP facilitated, but caregiver led 
(The CSNAT Approach),[18]. 
Delivery of the CSNAT-I followed the stages of the CSNAT Approach,[18]. First, the CSNAT was 
introduced to the caregiver by the HCP and/or research group during enrolment and once again 
when the HCP called the caregiver to plan a CSNAT conversation. Then, the caregiver was given 
time to consider in which areas he/she needed more support and complete the tool. Subsequently, a 
CSNAT conversation between the caregiver and the HCP was held, in which the caregiver had the 
opportunity to identify his/her individual support needs within the highlighted domains and was 
asked which support needs were the most urgent, what the caregiver felt would help him/her, and 
whether he/she needed assistance to access the support. The conversation formed the basis for 
developing a shared action plan which could contain e.g. the caregiver’s planned actions to access 
support or the HCP’s planned actions to facilitate support (by e.g. delivering support such as 
information or comfort, or to refer the caregiver to other services or sources of support such as a 
social worker or caregiver groups).  Finally, a shared review of the caregiver’s support needs and 
action plans was included in a second CSNAT-I.  
The CSNAT-I was delivered to each caregiver individually. The CSNAT was either self-completed 
(preferably) by the caregiver or completed jointly with the HCP. When possible, the subsequent 
conversation was carried out face-to-face, but phone and video were also allowed. The intervention 
was delivered by nurses in all SPC teams and additional professionals in some teams. The 
intervention was delivered twice to each caregiver:  first within 13 days of study enrolment and the 
second 15-27 days after enrolment (Figure 2). 
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Training  
All HCPs delivering the CSNAT-I received training from the research group (LL and LR). Training 
consisted of one group training session lasting 2-3 hours provided shortly before the shift to 
intervention period. The CSNAT training materials can be accessed via http://csnat.org. If needed, 
refresher training sessions were conducted during the intervention period.  
Documentation  
After each intervention, the HCP filled in a standardised documentation form describing the 
intervention framework (place, duration, etc.).  
Data collection and outcome measures 
Caregiver completed standard measures  
Outcome measures were collected at study enrolment (baseline, T0) and at follow-up two (T1) and 
four (T2) weeks later (Figure 2). These follow-up times were selected to minimize drop-out and to 
ensure that the intervention was also feasible for caregivers of patients with only a short survival 
time. The caregiver could choose paper questionnaires, electronic questionnaires, or telephone 
interviews. If the patient died during the study, subsequent data collection was cancelled.  
The primary outcome was caregiver strain at T1 assessed by the eight item strain subscale of the 
Family Appraisal of Caregiving Questionnaire for Palliative Care (FACQ-PC),[29]. 
Secondary outcomes were caregiver strain at T2 and the following at T1 and T2:  
Experiences of the interaction with HCPs 
 Lack of attention from HCPs to caregivers’ wellbeing (four item subscale); problems with 
quality of information from and communication with HCPs (seven item subscale); caregiver 
involvement (single item); and selected items from the subscale Lack of information from 
HCPs (six items, reported as one subscale as Cronbach’s Alpha: 0.88), all from the Cancer 
Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN),[13;30;31]. Minor 
adjustments were made to some CaTCoN items to adapt them to the current study 
(Appendix 1).  
 Talking to HCPs about greatest burdens and assistance from HCPs in managing greatest 
burdens, assessed by two newly developed items.  
Experiences of caregiving  
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 Caregiving workload, assessed by four items (selected from a five item subscale) from the 
CaTCoN,[13;30;31] 
 Positive caregiving appraisals and caregiver distress, assessed by the respective two 
subscales (four and seven items, respectively) from the FACQ-PC,[29]. 
Caregiver wellbeing  
 Emotional functioning and fatigue, assessed by subscales consisting of their respective four 
and three items from the EORTC Quality of Life Questionnaire Core 30 (EORTC QLQ-
C30),[32;32] each supplemented with three selected items from the EORTC Computerized 
Adaptive Test (EORTC CAT Core) emotional functioning and fatigue item banks, 
respectively,[33;34], in order to optimize measurement.  
 Positive emotional functioning (positive affect), assessed by a subscale (validation not 
published) of five positively formulated emotional functioning items (originally developed 
for the EORTC CAT Core emotional functioning item bank, but not included in the final 
version as they formed a distinct scale).  
Caregiver quality of life, assessed by the two-items subscale assessing overall health and quality of 
life in EORTC QLQ-C30,[32]. 
For each of the instruments, items and subscales were scored according to usual practice,[13;29;31-
37]. The FACQ-PC subscale scores were calculated when at least half of the items were completed. 
The two  newly developed items were scored using the CaTCoN scoring procedure,[13]. 
The questionnaire package (except the positively formulated emotional functioning items which 
were included later in the process) was evaluated in cognitive interviews with caregivers, ensuring 
that all items were understood in the context of the present study (Appendix 2). 
An overview of the complete caregiver questionnaire is given in Appendix 3. 
Caregiver and patient data 
Caregiver socio-demographic data concerning age, gender, relationship to the patient, level of 
education, employment, and place of residence were collected at baseline (included in the caregiver 
questionnaire).  
Data concerning enrolled patients’ diagnosis and SPC course as well as the total number of patients 
starting SPC at home in the study period in the participating SPC units were extracted from the 
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Danish Palliative Database (DPD). Patient age and gender were provided by the patient when 
consenting to data extraction. 
CSNAT-I data 
Data about delivery of the CSNAT-I were obtained from the HCPs’ documentation of the 
intervention (time, place, duration, whether the patient was present, and the HCP’s profession), and 
all SPC teams were asked to keep a record with the number of caregivers not participating in the 
study and reasons for non-participation. 
Translation 
The CSNAT and FACQ-PC were not available in Danish and were therefore translated following 
the EORTC Quality of Life Group translation procedure,[38].  
Sample size 
This study used the same primary outcome and principles for sample size estimation as the CSNAT 
study by Aoun,[19]: a moderate effect size of 0.41 for the primary outcome, a power of 0.80, and an 
adjustment for cluster effect of 1.62. The required sample size was 308 caregivers (154 in each 
group). We anticipated that at least 90% of those who consented would complete baseline measures, 
and that the drop-out at two weeks follow-up would be 30% (based on the study by Aoun et al. 
(2015) which had a mean follow-up time of 43 days and drop-out rate of 45%). Based on these 
assumptions, a total of 490 caregivers had to be enrolled.  
Statistical analyses  
All analyses were carried out in SAS Enterprise Guide v.7.11, using a level of significance of 5%. 
No imputations for missing data were made. 
Distribution of background variables in the intervention and control groups were compared using 
Chi
2
 and Wilcoxon rank sum tests.  
The effects of the intervention were assessed by comparing differences in change scores from 
baseline (T0) to follow-up at two (T1) and four weeks (T2) in the intervention and control group, 
respectively, using a multiple linear regression analysis, adjusting for background variables (shown 
in Table 1) as well as for baseline score. Effect sizes were calculated using Cohen’s d ( i.e., 0.2 
small; 0.5 medium; 0.8 large,[39]). Analyses were based on intention to treat. Two sensitivity 
analyses were carried out: a per protocol analysis (S1) where intervention caregivers who did not 
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receive the CSNAT-I were considered part of the control group, and an analysis excluding 
intervention caregivers who did not receive the CSNAT-I (S2).  Furthermore, a sensitivity analysis 
investigating the possible confounding effect of (calendar) time was carried out using Wilcoxon 
rank sum test.
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Table 1. Characteristics (self-reported and obtained from the Danish Palliative Database) of the 
participating 437 caregivers 
 
 TOTAL 
 
(n=437) 
INTERVENTION 
GROUP  
(n=182) 
CONTROL  
GROUP 
(n=255) 
P-value
a 
     
     
Gender    0.7971 
Male 135 (31%) 55 (30%) 80 (31%)   
Female 302 (69%) 127 (70%) 175 (69%)  
     
Age    0.0009  
Mean 59.8 57.3 61.7  
Median 61.0 58.0 63.0  
Range 23.0-90.0 23.0-84.0 24.0-90.0  
Missing 23 5  18  
     
Relationship to the patient    0. 0010 
Spouse/partner 27 (64%) 99 (57%) 171 (70%)   
(Adult) child 125 (30%) 69 (39%) 56 (23%)  
Other (e.g., parent, sibling, friend) 24 (6%) 7 (4%) 17 (7%)  
Missing 18 7  11   
     
Level of education    0.1149  
University education 60 (14%) 33 (19%) 27 (11%)  
Longer theoretical education (3-4 years) 152 (36%) 62 (35%) 90 (37%)  
Short theoretical education (1-3 years) 101 (24%) 36 (20%) 65 (26%)  
Other (short education (< 1 year), non-theoretical 
education, ongoing education, no education)  
  
110 (26%) 
  
46 (26%) 
 
64 (26%) 
 
Missing 14 5 9   
     
Employment    0.2909  
Currently working (full or part time) 148 (34%) 63 (35%) 85 (34%)  
Currently on sick leave or has care leave 92 (21%) 43 (24%) 49 (20%)  
Retired 169 (39%) 62 (35%) 107 (43%)  
Other (student, un-employed, housewife) 21 (5%) 11 (6%) 10 (4%)  
Missing 7 3 4  
     
Place of residence    0.1355 
City or suburbs 147 (34%) 64 (36%) 83 (33%)   
Provincial town 93 (22%) 33 (18%) 60 (24%)  
Village 98 (23%) 37 (21%) 61 (25%)  
Countryside 90 (21%) 46 (26%) 44 (18%)  
Missing 9 2 7  
     
Related to patients with     
     
          Gender    0.0880  
          Male 218 (50%) 82 (45%) 136 (53%)  
          Female 219 (50%) 100 (55%) 119 (47%)  
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Table 1, continued     
     
          Age    0.5388  
         Mean 69.2 69.5 69.0  
         Median 71.0 71.8 70.5  
         Range 27.1-96.9 29.9-90.6 27.1-96.9  
     
          Diagnosis     0.6550  
          Respiratory system cancer 93 (21%) 41 (23%) 52 (20%)  
          Breast cancer 42 (10%) 16 (9%) 26 (10%)  
          Pancreas cancer 37 (9%) 18 (10%) 19 (7%)  
          Colorectal cancer 38 (9%) 16 (9%) 22 (9%)  
          Prostate 36 (8%) 13 (7%) 23 (9%)  
          Gynecological cancer 26 (6%) 14 (8%) 12 (5%)  
          Upper gastrointestinal cancer 28 (6%) 11 (6%) 17 (7%)  
          Urinary cancer 22 (5%) 7 (4%) 15 (6%)  
          Cancer in brain and central nerve system 17 (4%)  9 (5%) 8 (3%)  
          Liver/biliary cancer 16 (4%) 9 (5%) 7 (3%)  
          Hematological cancer 14 (3%) 6 (3%) 8 (3%)  
          Head and neck cancer 12 (3%) 4 (2%) 8 (3%)  
          Other cancer (e.g., melanoma, sarcoma) 23 (5%) 10 (5%) 13 (5%)  
          Unknown cancer 9 (2%) 3 (2%) 6 (2%)  
          Not cancer (heart, lung, kidney or  
          neurological disease) 
 
24 (5%) 
 
5 (3%) 
 
19 (7%) 
 
     
          SPC team from     < 0.0001
b
  
          Bispebjerg Hospital 56 (13%) 36 (20%) 20 (8%)  
          Hospice Soendergaard 20 (5%) 9 (5%) 11 (4%)  
          South Jutland Hospital 58 (13%) 46 (25%) 12 (5%)  
          Arresoedal Hospice 24 (5%) 10 (5%) 14 (5%)  
          Diakonissestiftelsens Hospice 23 (5%) 12 (7%) 11 (4%)  
          North Zealand Hospital 61 (14%) 22 (12%) 39 (15%)  
          Odense University Hospital &  
          Hospital Svendborg 
 
95 (22%) 
 
29 (16%) 
 
66 (26%) 
 
          Rigshospitalet 30 (7%) 5 (3%) 25 (10%)  
          Zealand University Hospital           70 (16%) 13 (7%) 57 (22%)  
     
          Time from start SPI to study enrolment       
          (days)    0.0788 
          Mean 7.8 8.4 7.4  
          Median 6.0 6.0 5.5  
          Range 0.0-52.0 0.0-52.0 0.0-49.0  
          Missing 5 0 5  
     
a Chi Square for categorical variables and Wilcoxon for continuous variables 
b That different proportions of caregivers were recruited to either control or intervention group in the different SPC 
teams was due to and a natural consequence of the study design  
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RESULTS 
Study population  
For six SPC teams, the enrolment period was from 15
th
 March, 2018 to 15
th
 April, 2019 (extended 
by one month to increase sample size in the intervention group) (Figure 1). Start of enrolment in the 
remaining three teams was delayed due to practical matters and took place from 15
th
 June, 2018 to 
15
th
 June, 2019. To increase the sample size in the intervention group (due to slowing of caregiver 
enrolment in the intervention period), the largest SPC team shifted to the intervention period after 
six months instead of nine as decided by the randomisation (Figure 1). 
A study flow chart (CONSORT diagram) is shown in Figure 3. Consent rates (proportion 
consenting to participate out of those invited) were 50% and 34% in the control and intervention 
group, respectively. A total of 437 caregivers were enrolled: 255 in the control group; 182 in the 
intervention group. Ninety-one caregivers were lost to follow-up at T1 (exclusion/attrition rate: 
21%), and 139 at T2 (exclusion/attrition rate: 32%), resulting in 346 (T1) and 298 (T2) returned 
caregiver questionnaires.  
Caregivers predominantly chose to complete the baseline questionnaires on paper (87%) compared 
to electronically (12%) or over the phone (<1%) whereas they preferred to complete the follow-up 
questionnaires electronically (63%) followed by on paper (36%) and rarely over the phone (<1%).  
Characteristics of the 437 caregivers are shown in Table 1. Compared to the control group, the 
intervention group contained significantly more adult children of the patients (p=0.0010) and thus 
caregivers of younger age (p=0.0009). No other significant differences between caregivers in the 
two groups were found. 
The intervention 
Of the 142 caregivers in the intervention group completing the follow-up questionnaire at T1, 130 
(92%) had, as intended, received their first CSNAT-I. Of these, four caregivers (3%) had also 
received their second CSNAT-I. Twelve caregivers (9%) had not received a CSNAT-I. 
Of the 123 caregivers in the intervention group completing the follow-up questionnaire at T2, 93 
(76%) had, as intended, received two CSNAT-I. Twenty-five caregivers (20%) had received only 
one CSNAT-I, and five caregivers (4%) had still not received a CSNAT-I.  
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CSNAT conversations were carried out predominantly by a nurse (93% and 91% of the first and 
second conversations, respectively) and in the remaining cases by a social worker, priest, 
psychologist, physiotherapist, medical doctor, or a nurse and a medical doctor together. 
Most CSNAT conversations took place in out-patient clinics (37% and 35% of the first and second 
conversations, respectively) followed by the joint home of the patient and caregiver (24% and 22% 
of the first and second conversations, respectively) and over the phone (19% and 28% of the first 
and second conversations, respectively). ‘Other places’ and information not completed by the HCP 
totalled 20% and 15% of the first and second conversations, respectively. 
Ninety-seven percent and 98% of the first and second conversations, respectively, were conducted 
with the caregiver alone (i.e., without the patient being present).  
The mean duration of the first and second CSNAT conversations was 43 minutes (range 10-90) and 
32 (10-70) minutes, respectively. 
Effect of the intervention 
No significant effect of the intervention on the primary outcome, caregiver strain at T1, was found 
(p = 0.1865) (Table 2). 
However, at T1, positive intervention effects were found on caregiver distress (p = 0.0178, d  = 
0.12), attention to the caregivers’ wellbeing (p < 0.0001, d = 0.84), quality of information and 
communication (p < 0.0001, d  = 0.57), amount of information (p = 0.0002, d  = 0.51), 
responsibility in relation to home care (p = 0.0024, d  = 0.17), caregiver involvement (p = 0.0045, d  
= 0.49), talking about greatest burdens (p < 0.0001; d  = 0.98) and assistance in managing greatest 
burdens (p < 0.0001, d  = 0.75).  
At T2, positive intervention effects were found on attention to the caregivers’ wellbeing (p < 
0.0001, d  = 0.95), quality of information and communication (p < 0.0001, d  = 0.88), amount of 
information (p < 0.0001, d  = 0.73), caregiver involvement (p < 0.0001, d  = 0.70), talking about 
greatest burdens (p < 0.0001, d  = 1.10) and assistance in managing greatest burdens (p < 0.0001, d  
= 0.84).  
The two sensitivity analyses (S1 and S2) supported the findings from the main analysis, except that 
additional, positive intervention effects were seen at T1 on caregiver strain (primary outcome) (S1: 
p = 0.0048, d  = 0.28; S2: p = 0.0288, d  = 0.23) as well as on emotional functioning (S1: p = 
16 
 
0.0319, d  = 0.19), fatigue (S1: p = 0.0181, d  = 0.28; S2: p = 0.0433, d  = 0.25) and the caregivers’ 
provision of practical help to the patient (S1: p=0.0108, d  = 0.21).  
No confounding effect of (calendar) time was found. 
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Table 2. The intervention effect on the primary and secondary outcomes from the Family Appraisal of Caregiving Questionnaire for Palliative Care (FACQ-PC)a, the Cancer 
Caregiving Tasks, Consequences and Needs questionnaire (CaTCoN)b, the EORTC Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)c and EORTC Computerized Adaptive 
Test (EORTC CAT Core) item banksc, and two newly developed itemsb at T1 (two weeks follow-up) and T2 (four weeks follow-up).  
 Time Intervention Control Difference 
between 
change 
scores
d
 
Effect size 
(Cohen’s d) 
P
e
 
  N 
 
Baseline 
mean (SD)
  
Change from 
baseline to 2 
weeks follow-
up (SD) 
N 
 
Baseline 
mean (SD) 
 
Change from 
baseline to 2 
weeks follow-
up (SD) 
    
PRIMARY OUTCOME
           
Caregiver strain 
(FACQ-PC eight item subscale) 
T1 140 2.89 (0.78) -0.02 (0.48) 199 2.89 (0.79) 0.05 (0.47) -0.07 0.15 0.1865 
 T2 122 2.90 (0.74) -0.04 (0.52) 170 2.90 (0.76) 0.06 (0.54) -0.10 0.19 0.1533 
SECONDARY OUTCOMES
           
FACQ-PC           
Caregiver distress (four item subscale) T1 140 2.81 (0.95) -0.10 (0.69) 200 2.99 (0.92) -0.02 (0.70) -0.08 0.12 0.0178 
 T2 122 2.80 (0.98) -0.03 (0.73) 171 2.95 (9.96) 0.00 (0.73) -0.03 0.04 0.4424 
Positive caregiving appraisals (seven item subscale)  T1 141 4.06 (0.57) -0.08 (0.39) 200 3.96 (0.58) -0.05 (0.41) -0.03 0.08 0.6792 
 T2 123 4.08 (0.57) -0.10 (0.44) 169 3.95 (0.58) -0.05 (0.41) -0.05 0.12 0.4409 
CaTCoN           
Lack of attention from health care professionals to the 
caregivers’ wellbeing (four item subscale) 
T1 125 29.27 (24.25) -11.82 (22.81) 173 34.20 (26.55) 8.03 (24.62) -19.85 0.84 <0.0001 
 T2 110 30.13 (25.72) -12.42 (27.52) 144 34.57 (27.63) 14.47 (29.21) -26.89 0.95 <0.0001 
Problems with the quality of information from and 
communication with health care professionals (seven 
item subscale) 
T1 121 21.55 (15.73) -2.07 (15.34) 172 23.73 (18.63) 7.38 (17.50) -9.45 0.57 <0.0001 
 T2 102 20.90 (15.90) -3.17 (13.06) 139 23.66 (19.11) 11.12 (18.80) -14.29 0.88 <0.0001 
Lack of information from health care professionals (six 
item (modified) subscale) 
T1 130 42.03 (28.79) -10.11 (23.65) 186 41.71 (28.09) 2.65 (25.86) -12.76 0.51 0.0002 
 T2 113 41.05 (29.00) -15.05 (25.84) 154 42.36 (28.07) 4.39 (27.07) -19.44 0.73 <0.0001 
Provision of practical help (single item) T1 141 64.30 (32.52) -6.38 (27.86) 193 66.67 (31.37) -2.76 (25.76) -3.62 0.13 0.0981 
 T2 121 63.36 (31.74) -7.16 (35.54) 166 66.87 (30.81) -5.02 (27.86) -2.14 0.07 0.4277 
Provision of personal care (single item) T1 138 25.85 (30.41) -1.69 (21.43) 187 26.56 (31.14) 1.78 (25.57) -3.47 0.15 0.5960 
18 
 
 T2 120 25.56 (27.92) -1.39 (27.80) 157 23.57 (29.30) 4.25 (27.66) -5.64 0.20 0.5419 
Provision of psychological support (single item) T1 141 61.23 (32.76) -5.91 (30.42) 190 61.23 (31.42) 0.18 (25.77) -6.09 0.22 0.1255 
 T2 122 58.47 (32.72) -5.19 (30.91) 163 61.15 (31.48) -2.04 (32.44) -3.15 0.10 0.2817 
Too much responsibility in relation to home care  
(single item) 
T1 134 30.85 (33.86) -4.48 (31.07) 188 37.94 (34.16) 0.89 (31.49) -5.37 0.17 0.0024 
 T2 115 27.54 (31.92) 0.00 (32.74) 160 37.71 (33.25) 2.50 (30.27) -2.50 0.08 0.0902 
Caregiver involvement (single item) T1 113 20.65 (26.47) -3.83 (27.37) 151 21.85 (25.25) 11.70 (35.11) -15.53 0.49 0.0045 
 T2 97 20.62 (27.82) -6.19 (26.06) 123 22.22 (24.39) 15.45 (34.75) -21.64 0.70 <0.0001 
EORTC QLQ-C30           
Quality of life (two item subscale) T1 141 47.08 (8.83) -0.64 (6.44) 203 47.47 (8.53) -0.46 (7.48) -0.18 0.03 0.9274 
 T2 122 47.12 (8.61) -0.57 (7.63) 174 47.96 (8.25) -1.50 (8.97) 0.93 0.11 0.7534 
EORTC QLQ-C30 + EORTC CAT Core           
Emotional functioning, short-form (seven item 
subscale) 
T1 137 42.79 (7.78) 1.07 (6.01) 193 42.47 (8.41) 0.40 (6.32) 0.67 0.11 0.2446 
 T2 118 43.71 (8.06) 1.24 (7.53) 166 42.15 (8.75) 0.82 (6.58) 0.42 0.06 0.6286 
Fatigue, short-form (six item subscale) T1 137 56.55 (9.48) -0.05 (6.36) 194 55.41 (9.62) 0.84 (6.55) -0.89 0.14 0.1796 
 T2 116 55.79 (9.44) 0.19 (7.36) 164 55.36 (9.47) 0.79 (6.80) -0.60 0.08 0.7799 
EORTC CAT Core (excluded items)           
Positive emotional functioning (five item subscale) T1 141 45.55 (6.96) -0.32 (5.37) 201 45.29 (6.86) -0.41 (4.88) 0.09 0.02 0.6964 
 T2 121 45.71 (6.83) -0.50 (5.38) 172 45.60 (6.88) -0.20 (4.80) -0.30 0.06 0.6329 
Newly developed items           
Talking about greatest burdens (single item) T1 95 60.35 (32.72) -34.04 (38.59) 122 63.39 (34.66) 0.82 (32.49) -34.86 0.98 <0.0001 
 T2 83 60.24 (34.32) -38.96 (40.26) 109 67.28 (31.09) 1.83 (33.59) -40.79 1.10 <0.0001 
Assistance in managing greatest burdens (single item) T1 80 56.25 (32.52) -24.17 (32.68) 104 59.62 (36.18) 0.64 (33.16) -24.81 0.75 <0.0001 
 T2 70 56.19 (35.23) -29.52 (40.74) 90 60.37 (33.48) 3.70 (38.53) -33.22 0.84 <0.0001 
In the analyses, diagnosis was collapsed into eight groups (as opposed to 15 as shown in Table 1) 
SD: Standard deviation 
aExpressed on a scale of 1 (no strain/distress/positive caregiving appraisals) to 5 (maximum strain/distress/positive caregiving appraisals). Subscales are shown in Appendix 3.   
bExpressed on a scale of 0 (no problems/unmet needs/tasks) to 100 (maximum problems/unmet needs/tasks). Items and subscales are shown in Appendix 3.  
c Scores are transformed to T-scores, i.e., scored so the European general population has mean=50 and SD=10. The lower the score, the lower the level of quality of life, fatigue, emotional 
functioning, and positive emotional functioning. Subscales are shown in Appendix 3.   
dFor the outcomes ‘Positive caregiving appraisals’, ‘Quality of life’, ‘Emotional functioning’, and ‘Positive emotional functioning’, a positive value for the ‘Difference between change scores in 
intervention and control groups’ indicates that the intervention group had a more favourable development from baseline to follow-up than the control group. For all other outcomes, a negative 
value for the ‘Difference between change scores in intervention and control groups’ indicates that the intervention group had a more favourable development from baseline to follow-up than the 
control group.  
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eAll background variables shown in Table 1 and baseline score for the particular outcome were included in the multiple linear regression (non-reduced model)  
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DISCUSSION  
We found no effect of the CSNAT-I on the primary outcome, caregiver strain at T1, in the primary 
analysis. However, positive intervention effects were found at both T1 and T2 on the caregivers’ 
evaluation of attention to their wellbeing, quality of information and communication, amount of 
information, caregiver involvement, talking about greatest burdens and assistance in managing 
greatest burdens. For all of these outcomes, the effect sizes were found to be medium or large and 
seemed to increase from T1 to T2 (Table 2). Furthermore, at T1, positive effects were found on 
distress and home care responsibility. 
Lack of an intervention effect on the primary outcome may be due to increased caregiver strain 
being an inevitable consequence of providing end-of-life care for a loved one. However, it should 
be noted that a reduction in caregiver strain was found at T1 in both sensitivity analyses, and this 
may indicate some intervention effect. Furthermore, the positive intervention effect (d =0.35) after 
two CSNAT-Is reported by Aoun et al. (2015) was based on a per protocol analysis (i.e., as our 
sensitivity analysis S1), not on intention to treat analysis.  
Caregiver strain was chosen as the primary outcome as we wished to replicate the study by Aoun et 
al (2015), but in addition we included several secondary outcomes which we consider highly 
relevant and important for the caregivers.  The fact that the CSNAT-I had positive effects on 
caregiver distress, home care responsibility and a wide range of aspects of caregiver-HCP 
interaction is very encouraging.  
It is noteworthy that positive effects were obtained at T1, i.e. after one CSNAT conversation only, 
that is, an effect obtained quickly and with minimal intervention. This suggests that caregivers of 
patients with a very limited life expectancy have the potential to benefit from the intervention. 
Furthermore, as the effect sizes seemed to increase at T2, i.e. after two CSNAT conversations, a 
dose-response relationship is suggested, and further research could investigate the impact of 
additional interventions.  
Baseline levels of caregiver strain in the current study (2.89; 2.90) and in Aoun et al.’s (2015) study 
(2.92 in both groups) were very similar. However, it appears that a substantial proportion of 
caregivers were not informed about our project as HCPs judged the patient or caregiver too 
burdened for the caregiver to participate (Figure 3). This ‘gate keeping’ may have excluded some 
caregivers with a high level of caregiver strain (and/or other problems) and thereby a pronounced 
need for support from participation. 
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Our consent rates of 50% and 34% in the control and intervention group, respectively, indicate that  
compared to agreeing to complete standard measures only (i.e., in the control period), some 
caregivers may have perceived the CSNAT-I as time consuming and as an additional obligation 
they preferred to avoid. Therefore, when using the CSNAT-I in routine practice it should be 
introduced in a way that does not make caregivers feel that ‘this is an extra thing to deal with’ but 
rather as an opportunity to have a conversation about their support needs.     
A limitation of the study is that the SW-CRT design was not optimal due to differences in the sizes 
of SPC teams and the slower enrolment rate during the intervention period, and thus minor 
modifications to the study design were required to ensure sufficient statistical power in analyses. 
Another limitation is that randomisation was skewed regarding caregiver age and relationship to the 
patient. However, the study has significant strengths: it is the first multi-centre RCT investigating 
the effect of the CSNAT-I, and for a palliative care study where enrolment is a known difficulty it 
has a large sample size (i.e., 36% more caregivers than in the study by Aoun (2015)) and a low 
exclusion/attrition rate (32% at T2 vs. 45% in the study by Aoun et al (2015)).  
There are several areas of further research indicated by the present study. It would be highly 
relevant to investigate the Danish HCPs’ experiences of delivering the CSNAT-I and whether the 
intervention also has positive effects on the patients (e.g. on their acute hospitalizations, survival 
time and place of death). Positive HCP experiences and patient effects would further strengthen the 
case for implementation of the CSNAT-I as standard care in daily clinical practice. 
 
CONCLUSIONS 
This study of the CSNAT-I in the Danish SPC setting found no effect of the intervention on the 
primary outcome, caregiver strain at two weeks follow-up, in the primary analysis. Yet, positive 
intervention effects were found on caregiver distress and home care responsibility at two weeks 
follow-up and on several key outcomes regarding caregivers’ experience of the interaction with the 
HCPs at both two and four weeks follow-up, suggesting that the CSNAT-I is of great value to 
caregivers.  
 
 
Compliance with Ethical standards 
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The study was carried out in accordance with the 1964 Helsinki Declaration and its later 
amendments.  
The study was registered at ClinicalTrials.gov (ID: NCT03466580) and was approved by the 
Danish Data Protection Board (VD-2018-46). The protocol was presented to the Scientific Ethical 
Committee system (no. H-16042063) and was found not to require formal approval from the 
committee.  
Informed consent: Patient and caregiver gave informed consent to the caregiver’s participation in 
the study. Furthermore, the patients gave informed consent to extraction of data concerning their 
diagnosis and SPC course from Danish registers. 
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FIGURE LEGENDS 
 
Figure 1: The stepped wedge trial design of the study. The planned enrolment period for all 
participating SPC teams (i.e., clusters) was 12 months. The shift from control period to intervention 
period was after either 3 (period 1), 6 (period 2) or 9 (period 3) months. For six SPC teams, the 
enrolment period was extended by one month.  
 
Figure 2: Study course 
 
Figure 3: Study flow chart (CONSORT diagram) 
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